Zimmer Biomet Holdings (ZBH) Net Income towards Common Stockholders Growth (5y) (2014 - 2026)
Analysis
Zimmer Biomet Holdings (ZBH) Net Income towards Common Stockholders Growth (5y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.54 Bn | 177.94 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 124.25 Bn | 119.03 Bn | 1.96 Bn |
| 3 | Medtronic | 118.34 Bn | 109.52 Bn | 6.34 Bn |
| 4 | Stryker | 106.50 Bn | 103.03 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.56 Bn | 66.02 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.98 Bn | 32.52 Bn | 1.68 Bn |
| 8 | Dexcom | 32.07 Bn | 30.12 Bn | 830.00 Mn |
| 9 | Steris | 21.10 Bn | 20.61 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 18.27 Bn | 17.86 Bn | 1.54 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.97% |
| Mar 31, 2026 | 3.81% |
| Dec 31, 2025 | 8.43% |
| Sep 30, 2025 | -1.24% |
| Jun 30, 2025 | 22.31% |
| Mar 31, 2025 | 18.72% |
| Dec 31, 2024 | -16.23% |
| Sep 30, 2024 | -10.42% |
| Jun 30, 2024 | 13.01% |
| Mar 31, 2024 | -6.84% |
| Dec 31, 2023 | 18.72% |
| Sep 30, 2023 | 0.09% |
| Jun 30, 2023 | 2.57% |
| Mar 31, 2023 | 5.72% |
| Dec 31, 2022 | -47.78% |
| Sep 30, 2022 | 14.47% |
| Jun 30, 2022 | -3.51% |
| Mar 31, 2022 | -45.49% |
| Dec 31, 2021 | 4.25% |
| Sep 30, 2021 | -1.58% |